To further validate the clinical significance of CDK11p110 expression in patients with breast cancer, we detected CDK11p110 levels in a breast tumor tissue microarray by immunohistochemistry, and evaluated the correlation of CDK11p110 expression to the pathological characteristics and clinical prognosis of breast cancer patients. This evidence concerns the gene CDK11B and breast neoplasm.